LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
82.75 84.90 5633 8621 0.6534 0.8763
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
82.75 84.90 1352 8621 0.1568 0.5147
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
82.75 84.90 5383 8621 0.6244 0.8636
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 1073 8254 0.1300 0.4684
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 5797 8254 0.7023 0.8958
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 5772 8254 0.6992 0.8945
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 5800 8254 0.7026 0.8959
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 1348 8254 0.1633 0.5200
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
84.45 84.90 5529 8254 0.6698 0.8822
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 1168 8141 0.1435 0.4892
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 6019 8141 0.7393 0.9103
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 5950 8141 0.7308 0.9070
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 5971 8141 0.7334 0.9080
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 1441 8141 0.1770 0.5374
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
86.16 84.90 5716 8141 0.7020 0.8954
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 1235 7680 0.1608 0.5098
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 6214 7680 0.8091 0.9359
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 6143 7680 0.7998 0.9324
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 6161 7680 0.8022 0.9333
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 1524 7680 0.1984 0.5594
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
87.86 84.90 6006 7680 0.7820 0.9257
MN20160318_Q02
N12
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 1236 7494 0.1649 0.5134
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 6518 7494 0.8697 0.9573
MN20160318_Q02
G13
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 6314 7494 0.8425 0.9477
MN20160318_Q02
K07
MCF 10A-H2B-mCherry Trametinib
0.003
89.57 84.90 6343 7494 0.8463 0.9490
MN20160318_Q02
K07